CIRCULATE-NORTH AMERICA and Barriers to Enrollment

Stacey Cohen, MD, discusses the rationale and study design of the phase 2/3 CIRCULATE-NORTH AMERICA study evaluating adjuvant chemotherapy selection based on MRD, and the panel discusses barriers to enrollment.

Related Videos
John L. Marshall, MD
Petros Grivas, MD, PhD
E. Gabriela Chiorean, MD
E. Gabriela Chiorean, MD
Rene Adam, MD, PhD
Mazyar Shadman, MD, MPH
Video 14 - "Key Takeaways in HER2-Mutated NSCLC"
Video 13 - "Treatment Considerations in HER2-Mutated NSCLC"
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer